A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT04072952 · COMPLETED
Trial details
- NCT number
- NCT04072952
- Sponsor
- Arvinas Estrogen Receptor, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-05
- Primary completion
- 2024-09-13
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.